Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. (Q55476308)

12 July 2018

title

Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. (English)

1 reference

12 July 2018

0 references

Cho KH

1

1 reference

12 July 2018

Hall WA

2

1 reference

12 July 2018

Gerbi BJ

3

1 reference

12 July 2018

Higgins PD

4

1 reference

12 July 2018

McGuire WA

5

1 reference

12 July 2018

Clark HB

6

1 reference

12 July 2018

language of work or name

English

0 references

publication date

1 December 1999

1 reference

12 July 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

12 July 2018

volume

45

1 reference

12 July 2018

issue

5

1 reference

12 July 2018

page(s)

1133-1141

1 reference

12 July 2018

Ten-year survival among patients with supratentorial astrocytomas grade III and IV

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

The role of chemotherapy in recurrent malignant gliomas: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

Reoperation for recurrent glioblastoma and anaplastic astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

Stereotactic radiosurgery for recurrent malignant gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

Stereotactic radiosurgery for recurrent gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

The new WHO classification of brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

Relocatable frame for stereotactic external beam radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

Reirradiation of primary CNS tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

Operation and permanent low activity 125I brachytheraphy for recurrent high-grade astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

Hypofractionated stereotactic radiotherapy in the management of recurrent glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

Fractionated stereotactic radiosurgery and concurrent taxol in recurrent glioblastoma multiforme: a preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900336-3

7 January 2021

10.1016/S0360-3016(99)00336-3

Identifiers

DOI

1 reference

12 July 2018

PubMed ID

10613305

1 reference

12 July 2018